Skip to content

Effect of continuous infusion of dexmedetomidine on blood loss in orthognathic surgery: a retrospective study

Effect of dexmedetomidine on blood loss in orthognathic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018794
Enrollment
Unknown
Registered
2018-10-09
Start date
2018-11-01
Completion date
Unknown
Last updated
2018-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maxillary deformities

Interventions

Experimental group:dexmedetomidine
control group:none

Sponsors

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The hospital database contains a complete medical history, surgical records, and meet the following criteria: Patients who have undergone orthognathic surgeries (Le Fort sugery); More than 18 years of age;

Exclusion criteria

Exclusion criteria: Patients with a history of allergies to intraoperative related drugs; Patients with a history of heart-related diseases (NYHA class III or higher); Patients with a history of severe pulmonary disease (asthma, chronic obstructive pulmonary disease); Patients with a history of severe liver and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
blood loss;

Secondary

MeasureTime frame
Postoperative hemoglobin;Intraoperative heart rate;Intraoperative blood pressure;operation time;The incidence rate of homologous blood transfusion;ICU hospital stay;total hospital stay;

Countries

China

Contacts

Public ContactYu Sun

Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine

sunyu_9hospital@163.com+86 13611895542

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026